9-Jan-2009
Subscription Info
|
Institutional Access
|
Browse the Faculties
|
Free Trial
|
Take a Tour
|
Top 10s
|
Advanced Search
|
Faculty Member List
|
About
Search
All F1000 Medicine
Research Methodo...
Top 10s
Research Methodology
Current Top 10 by F1000 Factor
All Time Top 10 by F1000 Factor
Most viewed Top 10
(from all journals)
Most viewed Top 10
(from specialty journals)
Hidden Jewels
Sections Covered
Methods for Diagnostic & Therapeutic Studies
Methods of Clinical Decision-Making
Statistical Methodologies & Health Informatics
Teaching Evidence-Based Medicine
ALL TIME TOP 10 BY F1000 FACTOR | Research Methodology | calculated on 9 January 2009
All Time Top 10 By F1000 Factors are generated every day using papers added to F1000 Medicine since the project started (Top 10s consider papers evaluated in the preceding month). Papers are ranked according to their
F1000 Factor
which incorporates both the number of times a paper has been evaluated, and the ratings it received. If any papers have an equal F1000 Factor then the most recently added paper is listed first.
browse faculty
| show All Time Top 10 in
ALL OF MEDICINE
Anesthesiology & Pain Management
Cardiovascular Disorders
Critical Care & Emergency Medicine
Dermatology
Diabetes & Endocrinology
Gastroenterology & Hepatology
Hematology
Infectious Diseases
Nephrology
Neurological Disorders
Oncology
Psychiatry
Public Health & Epidemiology
Research Methodology
Respiratory Disorders
Rheumatology & Clinical Immunology
Urology
Women's Health
selected articles
all 10 items
to
EndNote
Ref. Manager
RefWorks
Bibtex
ProCite
email [
Help
]
1
Exceptional
F1000 Factor
9.0
New Finding
Controversial
An analysis of the controversy over classical one-sided tests.
Freedman LS
Clin Trials
2008
5
(6):635-40 [
abstract on PubMed
] [
related articles
] [
full text
] [
order article
]
Selected by
| Frank Harrell
Evaluated 23 Dec 2008
2
Exceptional
F1000 Factor
9.0
Hypothesis
New Finding
Tech Advance
Almost all articles on cancer prognostic markers report statistically significant results.
Kyzas PA, Denaxa-Kyza D, Ioannidis JP
Eur J Cancer
2007 Nov
43
(17):2559-79 [
abstract on PubMed
] [
related articles
] [
full text
] [
order article
]
Selected by
| Willi Sauerbrei
Evaluated 2 Jul 2008
3
Exceptional
F1000 Factor
9.0
Tech Advance
Use of randomised trials to decide when to monitor response to new treatment.
Bell KJ, Irwig L, Craig JC, Macaskill P
BMJ
2008 Feb 16
336
(7640):361-5 [
abstract on PubMed
] [
related articles
] [
full text
] [
order article
]
Selected by
| Rob Herbert
Evaluated 16 Apr 2008
4
Exceptional
F1000 Factor
9.0
Confirmation
Controversial
Preventive health care in elderly people needs rethinking.
Mangin D, Sweeney K, Heath I
BMJ
2007 Aug 11
335
(7614):285-7 [
abstract on PubMed
] [
related articles
] [
full text
] [
order article
]
Selected by
| Erik Buskens
Evaluated 6 Sep 2007
5
Exceptional
F1000 Factor
9.0
Confirmation
Hypothesis
New Finding
Tech Advance
Assessment of medical imaging systems and computer aids: a tutorial review.
Wagner RF, Metz CE, Campbell G
Acad Radiol
2007 Jun
14
(6):723-48 [
abstract on PubMed
] [
related articles
] [
full text
] [
order article
]
Selected by
| Yulei Jiang
Evaluated 31 Jul 2007
6
Exceptional
F1000 Factor
9.0
Tech Advance
Controversial
Refutation
When should epidemiologic regressions use random coefficients?
Greenland S
Biometrics
2000 Sep
56
(3):915-21 [
abstract on PubMed
] [
related articles
] [
full text
] [
order article
]
Selected by
| Frank Harrell
Evaluated 23 Jan 2007
7
Exceptional
F1000 Factor
9.0
Hypothesis
New Finding
Surrogate endpoints in clinical trials: definition and operational criteria.
Prentice RL
Stat Med
1989Apr
8
(4):431-40 [
abstract on PubMed
] [
related articles
] [
order article
]
Selected by
| Stephen Senn
Evaluated 14 Mar 2006
8
Exceptional
F1000 Factor
9.0
Tech Advance
Controversial
Evaluation of experiments with adaptive interim analyses.
Bauer P, Köhne K
Biometrics
1994Dec
50
(4):1029-41 [
abstract on PubMed
] [
related articles
] [
order article
]
Selected by
| Carl-Fredrik Burman
Evaluated 10 Jan 2006
9
Exceptional
F1000 Factor
9.0
New Finding
Controversial
Refutation
The performance of the two-stage analysis of two-treatment, two-period crossover trials.
Freeman PR
Stat Med
1989Dec
8
(12):1421-32 [
abstract on PubMed
] [
related articles
] [
order article
]
Selected by
| Stephen Senn
Evaluated 24 Nov 2005
10
Exceptional
F1000 Factor
8.0
Changes
Clinical Practice
New Finding
Tech Advance
Effectiveness of managing suspected pulmonary embolism using an algorithm combining clinical probability, D-dimer testing, and computed tomography.
van Belle A, Büller HR, …, Tick LW, Christopher Study Investigators
JAMA
2006 Jan 11
295
(2):172-9 [
abstract on PubMed
] [
related articles
] [
FREE full text
]
Selected by
| Joshua Fenton / Paul Stein
First evaluation 27 Jan 2006 | Latest evaluation 15 Feb 2006
© 2009 Medicine Reports Ltd unless otherwise stated.
< info@f1000.com >
Terms and conditions
Legal info